RAS Events
A key feature of the RAS Initiative’s ‘hub-and-spokes' model is to serve as an organizing force within the RAS community, promoting the exchange of information and bringing together leaders in the field to help quicken the pace of discovery. In efforts to achieve this aim, The RAS Initiative regularly hosts a symposium and participates in seminars, workshops, and conferences.
At the present time, all NIH-sponsored meetings are cancelled. We apologize for any inconvenience this may cause and appreciate your understanding.
Past Events
RAS Initiative Symposiums
The first RAS Initiative Symposium, held on December 15-16, 2015, attracted approximately 550 researchers to the Frederick National Laboratory for Cancer Research (FNLCR). The primary objective of this interactive forum was to mobilize the cancer research community towards finding therapeutic solutions to RAS-driven cancers. Since then, subsequent meetings have drawn thousands of researchers from government, industry, and academic institutions worldwide to discuss topics ranging from structural biology to novel therapeutic approaches. The meetings feature invited presentations, short presentations from selected abstracts, and poster presentations.
- Fifth RAS Initiative Symposium
October 8-10, 2024, Frederick, MD, USA - Fourth RAS Initiative Symposium
October 17–19, 2022, Frederick, MD, USA - Third RAS Initiative Symposium
May 24–26, 2021, virtual conference - Second RAS Initiative Symposium
December 6–8, 2017, Frederick, MD, USA - First RAS Initiative Symposium
December 15–16, 2015, Frederick, MD, USA
Other Seminars, Workshops, and Conferences
The following events engaged the wider community in tackling targeted questions in RAS biology, and shared knowledge acquired by our diverse team of scientists.
- Targeting RAS
March 5–8, 2023, Philadelphia, Pennsylvania - Fourth RAS-Targeted Drug Development Summit
September 26–29, 2022, Boston, Massachusetts - The Regulation and Function of Small GTPases
June 12–17, 2022, Saxtons River, Vermont - AACR Virtual Special Conference: Pancreatic Cancer
September 29–30, 2021, Virtual Conference - 7th International RASopathies Symposium
July 23–25, 2021, Virtual Conference - RAS-Targeted Drug Discovery
February 23 – 25, 2021, Virtual Conference - Precision Medicine for RAS Pathway Mutations in Cancer
December 8–9, 2020, Virtual Conference - Pancreatic Cancer: Advances in Science and Clinical Care
September 6–9, 2019, Boston, Massachusetts - Sixth International RASopathies Symposium
August 2–4, 2019, Baltimore, Maryland - The Regulation and Function of Small GTPases
June 23–28, 2019, Olean, New York - The RAS Superfamily and Related Pathways in Health and Disease
May 16–17, 2019, Santander, Cantabria, Spain - RAS Initiative Report at AACR Annual Meeting
April 1, 2019, Atlanta, Georgia - Targeting RAS-Driven Cancers
December 9–12, 2018, San Diego, California - Fifth NCI Pancreatic Cancer Symposium
October 2–3, 2018, Bethesda, Maryland - Frontiers in RAS Pathobiology and Drug Discovery
September 13–16, 2018, Stratton, Vermont - Small G Proteins in Cellular Signaling and Disease
July 9–12, 2018, Cambridge, UK - RAS Structure and Dynamics in Membranes Workshop
October 20, 2016 - Fully Processed KRAS Protein Purification Workshop
May 16–17, 2016 - RAS Initiative Small Business Workshop
February 25, 2016 - Synthetic Lethality Network Principal Investigators Meeting
December 14, 2015 - RAS Immunotherapy Workshop
November 3, 2015 - Biophysical and Structural Analysis of Processed KRAS
July 21–22, 2015 - Identifying Targets for Antibody, Nanoparticle, or Immune System Attack on KRAS Mutant Tumors
July 23, 2014 - RAS Pathway Modeling and Quantitative Measurements
June 11, 2014 - KRAS Synthetic Lethality Workshop
January 8–9, 2014